NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









AlphaLife Sciences

AlphaLife Sciences

Private
New JerseyHealthcare & Life Scienceshttps://alphalifesci.com/

Last Round

Accelerator

Sep 28, 2023

Momentum Score

50 /100

Company Overview

AlphaLife Sciences is a software company that provides a GenAI-powered platform to automate the clinical research process for the life sciences industry.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, RegTech, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

regulatory documentation automationmedical writing automationGenAI platformAI for life sciencesPharma AIAI copilotclinical research automationdrug development softwareRegTechregulatory submissionsCRO softwareVeeva integrationGxP compliance21 CFR Part 11AI authoring services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AlphaLife Sciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AlphaLife Sciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 28, 2023

Key People

Founding team and executive leadership

Gavin Zhang

Co-Founder & Chief Business Officer

Founding Team

Sharon Chen

Founder And CEO

Founding Team

Bogong Zhu

Chief Product Officer

Executive Team

AlphaLife Sciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Grew 32% QoQ, from 22 to 29 employees.

  • Jan 1, 2026

    Monthly visitors grew 104% MoM, reaching 5.1K.

AlphaLife Sciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AlphaLife Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AlphaLife Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Jersey
Employee Range29
Year Founded2020
Last FundingSep 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.